https://european-biotechnology.net/wp-content/uploads/2025/04/Gerwert-e1745833045409.jpg
450
799
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-28 10:00:352025-04-28 10:00:35betaSense GmbH identifies new diagnostic biomarker for Parkinson’s
https://european-biotechnology.net/wp-content/uploads/2025/04/Oryzon-Genomics-e1745831558599.jpg
358
614
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-28 09:14:432025-04-28 09:14:43Oryzon cashes in €30m
https://european-biotechnology.net/wp-content/uploads/2025/04/CY-101-MOA-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-24 06:39:042025-04-24 06:39:04Cytovation ASA bags additional US$6m to drive Phase II study
https://european-biotechnology.net/wp-content/uploads/2025/04/aktie.traderfox.png
379
948
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-23 13:24:162025-04-23 13:24:16KKR makes US$1.22bn tender for Swedish Biotage AB
https://european-biotechnology.net/wp-content/uploads/2025/04/BI_1000_F_644085627_JtBMxLtbNtTIGHcIW9XYXoQOfwFZwBU8.jpg
667
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-23 11:27:252025-04-23 15:32:02Boehringer Ingelheim inks deal with Tessallate Bio
https://european-biotechnology.net/wp-content/uploads/2025/04/pharma-tariffs_1000_F_127114908_Af4TT80EpqcXxWWKOylZ84ms69Y1zgl0.jpg
536
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-23 10:53:452025-04-23 13:32:03Roche and Novartis react to US tariffs
https://european-biotechnology.net/wp-content/uploads/2025/04/2148610622-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-22 10:15:242025-04-22 10:15:24Whey Waste Finds New Life as Protein
https://european-biotechnology.net/wp-content/uploads/2025/04/Uniqure-striatum-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-18 09:23:462025-04-18 09:23:46AMT-130 gets FDA breakthrough therapy designation
https://european-biotechnology.net/wp-content/uploads/2025/04/eb-250417-netherlands-biotech-beljaarts-jansen-1030x687-1.jpg
687
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-17 07:01:272025-04-17 07:01:27Netherlands Sets Sights on Global Biotech Leadership
https://european-biotechnology.net/wp-content/uploads/2025/04/Polyneuron_123rf.com_guniita78848312_s.jpg
544
880
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-04-16 07:41:112025-04-16 11:02:01NLS and Kadimastem: Swiss-israeli merger in ALS
Scroll to top
